Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Novartis AG    NOVN   CH0012005267

NOVARTIS AG

(NOVN)
  Report
Delayed Quote. Delayed Swiss Exchange - 11/27 09:13:33 am
80.85 CHF   -0.50%
07:09aNOVARTIS AG : Barclays reaffirms its Sell rating
MD
11/26Business rights or human rights? Swiss vote shines spotlight on companies
RE
11/25NOVARTIS : Genmab Announces Enapotamab Vedotin Update
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Capitalization1 196 548197 469214 715203 862--
Entreprise Value (EV)1 215 548213 669230 615223 130218 587212 857
P/E ratio 25,1x15,4x29,5x24,4x19,2x17,4x
Yield 3,60%3,39%3,29%3,52%3,66%3,78%
Capitalization / Revenue 4,00x3,80x4,53x4,12x3,88x3,72x
EV / Revenue 4,39x4,12x4,86x4,51x4,16x3,88x
EV / EBITDA 14,9x13,7x14,6x13,4x11,9x10,9x
Price to Book 2,57x2,47x3,75x3,60x3,44x3,24x
Nbr of stocks (in thousands) 2 327 3402 309 9732 264 6082 274 506--
Reference price (USD) 82,484,091,989,689,689,6
Last update 01/24/201801/30/201901/29/202011/26/202011/26/202011/26/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net sales1 49 10951 90047 44549 43552 51554 795
EBITDA1 14 49215 64615 80916 59418 33319 439
Operating profit (EBIT)1 12 85013 82314 11215 58517 00218 264
Operating Margin 26,2%26,6%29,7%31,5%32,4%33,3%
Pre-Tax Profit (EBT)1 8 99913 8358 94010 27112 73913 912
Net income1 7 70312 6117 1478 32610 39311 300
Net margin 15,7%24,3%15,1%16,8%19,8%20,6%
EPS2 3,285,443,123,674,685,14
Dividend per Share2 2,972,853,023,163,283,39
Last update 01/24/201801/30/201901/29/202011/26/202011/26/202011/26/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2017 2018 2019 2020 2021 2022
Net Debt1 19 00016 20015 90019 26814 7258 996
Net Cash position1 ------
Leverage (Debt / EBITDA) 1,31x1,04x1,01x1,16x0,80x0,46x
Free Cash Flow1 10 42811 71712 87512 83014 27716 089
ROE (Net Profit / Equities) 15,3%16,5%17,5%23,7%25,4%26,4%
Shareholders' equity1 50 38076 39140 84235 15840 91242 839
ROA (Net Profit / Asset) 5,85%9,05%8,89%7,10%9,00%-
Assets1 131 601139 32180 393117 264115 476-
Book Value Per Share2 32,034,024,524,926,127,7
Cash Flow per Share2 5,375,385,885,626,637,26
Capex1 1 6961 7732 2571 5951 7541 767
Capex / Sales 3,45%3,42%4,76%3,23%3,34%3,22%
Last update 01/24/201801/30/201901/29/202011/25/202011/26/202011/26/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (CHF)
184 826 376 737
Capitalization (USD)
203 854 120 328
Net sales (USD)
47 445 000 000
Number of employees
110 000
Sales / Employee (USD)
431 318
Free-Float
86,9%
Free-Float capitalization (CHF)
160 693 429 834
Free-Float capitalization (USD)
177 236 703 764
Avg. Exchange 20 sessions (USD)
601 849 789
Average Daily Capital Traded
0,33%
EPS & Dividend